ClinicalTrials.Veeva

Menu

E-cadherin and Integrin Alpha v Beta 1 in Vitiligo

K

Kasr El Aini Hospital

Status

Unknown

Conditions

Vitiligo

Treatments

Device: Narrow band UVB

Study type

Interventional

Funder types

Other

Identifiers

NCT05287776
EcadVitiligo

Details and patient eligibility

About

The purpose of this clinical trial is to study the effect of Narrow Band UVB on E-cadherin and integrin alpha v beta 1 as representatives of adhesion molecules in non-segmental vitiligo in a trial to verify a novel proposed mechanism of Narrow Band UVB. Additionally, specific melanocyte marker (Melan A) will be done to settle the localization of adhesion molecules in relation to melanocytes.

Enrollment

15 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All clinically diagnosed cases of non-segmental vitiligo .
  • Patients with VIDA +1 or more (new/expanding lesions active in time period of 6-12 months ago) will be included in the trial. Activity of vitiligo will be evaluated through Vitiligo Disease Activity (VIDA) Score.

Exclusion criteria

  • Patients who have stable disease at the time of study i.e. no progression of existing disease or appearance of new lesions in the last six months.
  • Patients receiving treatment for vitiligo 3 months prior to the study.
  • Patients with contraindications for phototherapy.
  • Patients with current/history of any systemic and/or dermatological diseases affecting the immune system as autoimmune diseases and malignancy.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Sequential Assignment

Masking

None (Open label)

15 participants in 1 patient group

15 patients with vitiligo subjected to NB-UVB
Experimental group
Description:
Patients will be subjected to NB-UVB sessions 3 times weekly. The UVB dosing scheme in the patients receiving only NB-UVB treatment entailed initial dosing at 0.5 J/cm2 with increasing increments by 0.3 J/cm 2 every other session until faint erythema occurs.
Treatment:
Device: Narrow band UVB

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems